Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Tetragon Financial Group Limited: PERFORMANCE REPORT FOR PERIOD ENDED 30 SEPTEMBER 2015
-
Sunesis Pharmaceuticals Reports Third Quarter 2015 Financial Results and Recent Highlights
-
Notable Analyst Rating Changes 11/4: (NOK) (OCLR) (EVDY) Upgraded; (KMT) (AIG) (MNKD) Downgraded
-
Cantor Fitzgerald Starts Tonix Pharma (TNXP) at Buy
-
Cantor Fitzgerald Starts Flexion Therapeutics (FLXN) at Buy
-
Cantor Fitzgerald Starts Egalet Ltd (EGLT) at Buy
-
Cantor Fitzgerald Starts DepoMed Inc (DEPO) at Buy
-
Cantor Fitzgerald Starts Cara Therapeutics (CARA) at Buy
-
Cantor Fitzgerald Starts BioDelivery Sciences International (BDSI) at Buy
-
Cantor Fitzgerald Starts Culp, Inc. (CFI) at Hold
-
Adam Futterman Joins LEERINK Partners Institutional Equities Team
-
Roka Bioscience (ROKA) Announces Controlled Equity Offering Sales Agreement
-
Cantor Fitzgerald Downgrades Aaron's (AAN) to Hold
-
Cantor Fitzgerald Upgrades Fluidigm Corporation (FLDM) to Buy
-
Orchid Island Capital Announces Third Quarter 2015 Results
-
Cytokinetics, Inc. Reports Third Quarter 2015 Financial Results
-
CIBL Announces Filing Of Its SPAC's Registration Statement
-
Rosetta Genomics Reports Financial Results for the First Half of 2015
-
Cantor Fitzgerald Starts Ignyta, Inc (RXDX) at Buy
-
Cantor Fitzgerald Starts Mirna, Inc. (MIRN) at Buy
-
Dimension Therapeutics (DMTX) IPO Opens Modestly Lower
-
Dimension Therapeutics Announces Pricing of Initial Public Offering
-
Dimension Therapeutics Announces Pricing of Initial Public Offering
-
Broadridge Expands EMEA Team to Support Global Financial Institutions
-
TPG Specialty Lending, Inc. Reiterates Importance of Protecting Stockholder Value by Voting AGAINST All Proposals at Upcoming TICC Capital Corp. Special Meeting
-
In Light of Significant Growth, Dynasty Financial Partners Expands its Footprint and Leadership Team
-
Cantor Fitzgerald Starts IBM (IBM) at Hold
-
Cantor Fitzgerald Starts Computer Sciences (CSC) at Hold
-
Cantor Fitzgerald Starts Infosys Technologies (INFY) at Hold
-
Cantor Fitzgerald Starts Syntel, Inc. (SYNT) at Hold
-
Cantor Fitzgerald Starts Cognizant Technology Solutions (CTSH) at Buy
-
Cantor Fitzgerald Starts WNS (Holdings) (WNS) at Buy
-
Cantor Fitzgerald Starts Exlservice (EXLS) at Buy
-
Cantor Fitzgerald Starts Genpact Ltd. (G) at Buy
-
Cantor Fitzgerald Starts Globant S.A. (GLOB) at Hold
-
Cantor Fitzgerald Starts Accenture plc (ACN) at Buy
-
Cantor Fitzgerald Starts Virtusa (VRTU) at Buy
-
Profile Technologies (PRTK) Enters $50M Controlled Equity Offering Agreement
-
FallLine Securities LLC Names Michael R. Gault Partner and Head of Client Services
-
Signal Hill Hires Senior Banker, Grows Capabilities in Private Placements
-
TPG Specialty Lending, Inc. Questions Payment to Failed Leadership in Letter to TICC Capital Corp. Stockholders
-
Notable Analyst Rating Changes 10/9: (ALB) (MT) (RPD) Upgraded; (FEYE) (TSLA) (PCAR) Downgraded
-
Sturdy quarter likely for financials, but ETF investors cautious
-
Cantor Fitzgerald Starts Ocata (OCAT) at Buy
-
Orchid Island Capital Announces October 2015 Monthly Dividend and September 30, 2015 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Starts Barnes & Noble Education (BNED) at Hold
-
Cantor Fitzgerald Starts Gannett (GCI) at Buy
-
Cantor Fitzgerald Starts Madison Square Garden (MSG) at Buy
-
Cantor Fitzgerald Starts MSG Networks (MSGN) at Hold
-
Cantor Fitzgerald Starts KLX Inc (KLXI) at Buy


